NEWS
Our Latest News
ARCHIMED buys Denmark’s DermaPharm A/S, a leading developer and manufacturer of skincare products
Global private equity healthcare specialist ARCHIMED announces the acquisition of DermaPharm A/V. DermaPharm is a leading player in Nordic suncare and a world-renowned skincare contract development & manufacturing organization for third parties.
ARCHIMED creates a leading specialized dermatological-focused CRO via the simultaneous purchase & merger of Symbio and Proinnovera
November
17,
2023
ARCHIMED top-ranked buyout fund MED I earns 4.5x on the sale of Vita
October
27,
2023
ARCHIMED Publishes White Paper – “Navigating the FHIR Landscape: A Strategic Approach for Healthcare IT Businesses”
September
27,
2023
368